Biomedica Immunoassays

First FGF23 (C-terminal) ELISA
for both serum and plasma samples

High Sensitive FREE soluble RANKL ELISA
Measurable concentrations in healthy subjects

Bone Metabolism

Biomedica offers ELISA kits for the determination of biomarkers of bone metabolism. Our assay portfolio ranges from Osteoprotegerin and a highly sensitive free soluble RANKL assay to biomarkers of the Wnt signaling pathway such as Sclerostin and DKK-1.

Our ELISA assays are fully validated to ensure high quality and reproducibility. Every kit includes five to seven calibrators and one to two controls in a human serum matrix, thus allowing researchers to collect biologically reliable data.

Cardiovascular

Biomedica offers ELISA kits for the determination of biomarkers in cardiovascular disease. Our assay portfolio ranges from natriuretic peptides, such as NT-proBNP and NT-proANP, to the Endothelins including Big ET and ET. Osteoprotegerin, a regulator of bone metabolism has evolved to a biomarker of cardiovascular disease.

Our ELISA assays are fully validated to ensure high quality and reproducibility. Every kit includes five to six calibrators and one to two controls in a human serum matrix, thus allowing researchers to collect biologically reliable data.

Oxidative Stress

Biomedica's oxidative stress product line covers biomarkers for risk stratification (OxyStat and MDA-oxidized LDL) and one biomarker to determine the severity of disease (oLAB - anti oxidized LDL autoantibodies).

Our ELISA assays include six calibrators and one to two controls in human serum matrix, thus allowing researchers to collect biologically reliable data.

Nephrology & Transplant

Biomedica offers ELISA kits for the determination of biomarkers in kidney disease. Our assay portfolio ranges from FGF23 (fibroblast growth factor 23) to Endostatin. The C4d antibody complements this product line as marker of humoral transplant rejection.

Our ELISA assays are fully validated to ensure high quality and reproducibility. Every kit includes six or seven calibrators and one or two controls in a human serum matrix, thus allowing researchers to collect biologically reliable data.  

Lyme Disease

Biomedica offers ELISA kits for the diagnostic screening of Lyme Borreliosis - Borrelia recombinant IgG ELISA and Borrelia recombinant IgM ELISA. The combination of antigens used in both Borrelia assays detect antibodies directed against the different Borrelia species, pathogenic for humans, including B. burgdorferi senso strictu.

Our Borrelia assays are fully validated ELISAs to ensure high quality and reproducibility of the results. Results are further confirmed by regular participation in external quality control circles. Each kit includes ready to use reagents and can process serum, plasma, and liquor samples.

Other Products

Biomedica offers a non-radioactive cell proliferation and cytotoxicity assay as well as reagents for the elimination of rheumatoid factor in serum and plasma. A range of polyclonal antibodies to PTHrP, proANP, proBNP, proCNP, Endothelin, big Endothelin, Urodilatin, MGP, Cathepsin K, and RANKL are available.